AlphAIalphai — Financial news for AI agents
financialcontent.comJUL 284 min read$BUSE

First Busey (NASDAQ:BUSE) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

First Busey (NASDAQ:BUSE) reported Q2 CY2026 results with revenue up 1.3% year over year to $194.5 million, below analyst estimates. Non-GAAP EPS was $0.69, 7.1% above consensus. The article also cites net interest income as the main revenue driver and notes the stock was about $30.20 after the report.

Original reporting
financialcontent.com
Published Jul 28, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
First Busey (NASDAQ:BUSE) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Source · financialcontent.com
Decision brief

The 30-second read

$BUSENeutralMed
01

Why it matters

The key trade signal is a Q2 revenue miss versus consensus, partially offset by a non-GAAP EPS beat, with net interest income also slightly below expectations.

02

Market read

Traders can reassess near-term expectations for revenue growth and net interest income while monitoring whether TBVPS acceleration persists.

03

What to watch

The article highlights TBVPS growth acceleration (to $20.40 from $16.97 over two years) and consensus TBVPS growth of 9.7% over 12 months, which may support valuation despite the quarterly revenue miss.

Relevance 6/10Novelty 6/10Timing: after-hours/late-day reaction to Q2 CY2026 results

Background

First Busey is a regional bank holding company with commercial and retail banking, wealth management, and payment technology operations.

Company-level read

Ticker impact

$BUSENeutralMedium confidence
Context

First Busey reported Q2 CY2026 revenue of $194.5M, up 1.3% YoY, which fell short of Wall Street estimates.

Expected impact

Likely choppy trading, with downside risk if investors focus on the revenue and net interest income shortfall.

Evidence & confidence

The article provides a concrete revenue miss ($194.5M, +1.3% YoY) alongside a non-GAAP EPS beat ($0.69), plus notes net interest income slightly missed and the stock was flat at $30.20 immediately after reporting.

Market effects

Sector

Adds another datapoint on regional bank revenue sensitivity, especially net interest income versus non-interest income.

Regional

Limited to regional banking sentiment, with potential read-across to Midwest/Sunbelt bank peers.

Global

Low, as it is a single-company earnings datapoint without broader macro/regulatory triggers.

Counterpoint

What could challenge this read

EPS outperformance and accelerating TBVPS growth could offset the revenue miss if investors believe the NII shortfall is temporary.

Key entities

  • company
    First Busey

    Reported Q2 CY2026 results: revenue $194.5M (+1.3% YoY) and non-GAAP EPS $0.69, with revenue and NII slightly missing estimates.

Read at source← All news

Related articles

JUL 28
$BUSEMed

FIRST BUSEY CORP /NV/ (BUSE): Results of Operations and Financial Condition

FIRST BUSEY CORP /NV/ (BUSE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 buse_20260728x26q2xex991.htm EX-99.1 Document F I R S T B U S E Y C O R P O R A T I O N A N N O U N C E S 2 0 2 6 S E C O N D Q U A R T E R E A R N I N G S Q 2 | 2 0 2 6 www.busey.com INVESTOR CONTACT: Tate McKay, Director of Investor Relations and Corporate Development

SEC EDGAR 8-K6 min
MAY 27
$BUSEMedAI 9/10

First Busey (NASDAQ:BUSE) Hits New 12

First Busey (NASDAQ:BUSE) reached a new 52-week high on Wednesday, trading up to $27.78 and last at $27.4010 versus a prior close of $27.08. The bank reported Q1 EPS of $0.67 (vs. $0.57 consensus) on revenue of $197.17 million. It also declared a $0.26 quarterly dividend and analysts cited a $27.50 consensus target.

dailypolitical.com4 min
AUG 8
$NNNMed

NNN REIT Q2 Earnings Call Highlights

NNN REIT (NYSE:NNN) reported Q2 earnings call highlights. It cut its full-year bad-debt outlook to about 40 bps from 60 bps, kept second-half credit-loss assumptions, and raised the annual disposition guidance midpoint by $10 million to $140 million. In Q2 it invested $290M in 89 properties, occupancy rose to 99.1%, and it declared a $0.62/share dividend.

yahoo.com6 min
AUG 8
$NTRMed

Nutrien Q2 Earnings Call Highlights

Nutrien’s CEO Ken Seitz said the company used automation to mine 53% of ore tons in the first half, exceeding its 2024 target range. Nutrien maintained 2026 potash shipment guidance of 74-77 million tons and 2026 nitrogen sales-volume guidance of 9.2-9.7 million tons. Q2 nitrogen adjusted EBITDA was $635 million. The company cut 2026 capex guidance to $1.95B-$2.05B and raised share repurchases to about $75M/month.

yahoo.com6 min
AUG 8
$NVGSMed

Navigator Q2 Earnings Call Highlights

Navigator Holdings (NYSE:NVGS) reported Q2 updates. Its 2026 all-in cash breakeven rose to $21,990 per vessel per day from $21,230, citing the pending sale of eight Unigas Pool vessels. Morgan’s Point ethylene terminal set a record 374,278 tonnes; Navigator’s equity income was $7.1m. It sold Navigator Pegasus for $30.5m and expects Unigas sales net proceeds about $129m and book gains $65m-$70m. Dividend $0.07/share; Q3 TCE and volumes expected to moderate.

yahoo.com6 min
AUG 8
$NUVBMed

Nuvation Bio Q2 Earnings Call Highlights

Nuvation Bio (NUVB) reported Q2 call highlights for IBTROZI in ROS1-positive lung cancer, citing TRUST-I results in TKI-naive patients with a 90% objective response rate and 50-month median response duration and progression-free survival. The company said first-line ROS1 TKI use rose nearly 20% through May 2026. It also updated safusidenib Phase II J201 (52% ORR, 79% 36-month PFS) and outlined Phase III/G307 and G209 studies. Cash was $661M after a June convertible notes offering.

yahoo.com6 min